🕵️ Viking Therapeutics, Inc. ($VKTX)
SEC insider & ownership activity, last 12 months · CIK 1607678 · every row links its SEC filing
Over the last 12 months insiders sold $22.3M against $150K of open-market buying. Brian Lian sold $14.0M (Oct–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $150K (1 lots) · 5 sellers, $22.3M (20 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Brian Lian | 0 | – | 6 | $14.0M | Jul 29, 2026 |
| Greg Zante | 0 | – | 6 | $2.8M | Jul 29, 2026 |
| Marianna Mancini | 0 | – | 6 | $2.7M | Jul 29, 2026 |
| Charles A Rowland Jr. | 0 | – | 1 | $2.1M | Oct 27, 2025 |
| Matthew W. Foehr | 0 | – | 1 | $562K | Jan 2, 2026 |
| Aubuchon Neil William | 1 | $150K | 0 | – | Mar 10, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 5.1% | 13G | Nov 5, 2025 | filing ↗ | |
| Abigail P. Johnson | 5.1% | 13G | Nov 5, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.1% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Brian Lian | $4.9M | Jul 29, 2026 | filing ↗ |
| Greg Zante | $710K | Jul 29, 2026 | filing ↗ |
| Marianna Mancini | $610K | Jul 29, 2026 | filing ↗ |
| Marianna Mancini | $1.9M | Jan 5, 2026 | filing ↗ |
| Greg Zante | $1.9M | Jan 5, 2026 | filing ↗ |
| Brian Lian | $7.7M | Jan 5, 2026 | filing ↗ |
| Matthew W. Foehr | $562K | Jan 2, 2026 | filing ↗ |
| Greg Zante | $217K | Oct 28, 2025 | filing ↗ |
| Marianna Mancini | $216K | Oct 28, 2025 | filing ↗ |
| Brian Lian | $1.4M | Oct 28, 2025 | filing ↗ |
| Charles A Rowland Jr. | $2.1M | Oct 27, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 19, 2026 | filing ↗ |
| Earnings (2.02) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Earnings (2.02) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Earnings (2.02) | Oct 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 22, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 19, 2025 | filing ↗ |